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ABSTRACT
Magnetic resonance imaging (MRI) is the preferred 
imaging technique for the sellar and parasellar regions. 
In this review article, we report our clinical experience 
with MRI for hypothalamic and pituitary lesions, 
such as pituitary adenomas, craniopharyngiomas, 
Rathke cleft cysts, germinoma, and hypophysitis with 
reference to the histopathological findings through a 
review of the literature. Our previous study indicated 
that three dimensional-spoiled gradient echo sequence 
is a more suitable sequence for evaluating sellar le-
sions on postcontrast T1 weighted image (WI). This 
image demonstrates the defined relationship between 
the tumor and its surroundings, such as the normal 
pituitary gland, cavernous sinus, and optic pathway. 
We demonstrated the characteristic MRI findings of 
functioning pituitary adenoma. In growth hormone-
producing adenoma, signal intensity on T2WI is impor-
tant to differentiate densely from sparsely granulated 
somatotroph adenomas. In prolactin-producing pituitary 
adenomas, distinct hypointense areas in early phase on 
T2WI, possibly owning to diffuse hemorrhage, indicate 
pronounced regressions of invasive macroprolactinomas 
during cabergoline therapy. The two histopathological 
subtypes, adamantinomatous and squamous papillary 
craniopharyngioma, differ in genesis. Calcified tumors 
are mostly adamantinomatous type. On MRI, these 
lesions have a heterogenous appearance with a solid 
portion and cystic components. The solid portions and 
cyst wall enhance heterogeneously. Although cyst fluid 
of Rathke cleft cysts show variable intensities on MRI, 
intracystic waxy nodule can be hypointense on T2WI. 
The enhancing cyst wall may contain the squamous 
metaplasia. Cystic lesions of the sellar and parasellar 
areas may be difficult to differentiate on a clinical, 
imaging, or even histopathological basis.
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Magnetic resonance imaging (MRI) is the preferred im-
aging technique for the sellar and parasellar regions.1, 2 
Several different lesions occur around this area. High-
f ield MRI is a recent advancement in medical 
imaging.3–5 A three-tesla (3T) MRI unit was introduced 
into our hospital in December 2003. Recently, we have 
used two 3T MRI machines. At 3T, three dimensional 
(3D)-spoiled gradient echo (SPGR) sequence provided 
significantly better images than the spin-echo (SE) 
sequence in terms of the border of sellar lesions and 
delineation of the cranial nerves.3
A 3D-SPGR sequence has been used for the T1WI, 
and for the T2WI a fast SE sequence was routinely used 
for the diagnosis of the sellar lesions. In some cases, 
susceptibility WI6 and/or arterial spin-labeled perfusion 
imaging (ASL) has been used. We advocated the 3T 
MRI state-of-the-art technique that provided significant 
assistance as a diagnostic and therapeutic tool for the 
treatment of hypothalamic and pituitary tumors.
PITUITARY HYPERPLASIA
Pituitary hyperplasia is a nonneoplastic increase in cell 
number of the anterior pituitary gland. Physiological 
pituitary hyperplasia is common in pubescent females.7 
Pituitary gland enlargement also occurs during preg-
nancy. Pathological hyperplasia often occurs in response 
to target organ failure. MRI reveals a diffuse enhanced 
symmetric lesion in the sellar region. For example, long-
standing untreated primary hypothyroidism can cause 
pituitary hyperplasia owing to hormonal-feedback 
mechanisms. The thyrotropin level normalized and en-
hanced lesion decreased considerably during thyroxine 
replacement therapy in most cases (Fig. 1). Pathological 
hyperplasia, such as growth hormone (GH) or adreno-
corticotropic hormone (ACTH) cell hyperplasia, can 
also be induced by excessive releasing hormones.
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PITUITARY ADENOMA
Adenomas 10 mm in diameter or more are defined as 
macroadenomas, which are easily diagnosed; however, 
they require careful delineation. In our previous study,3 
3T MRI, particularly three dimensional (3D)-spoiled 
gradient echo (SPGR) sequence demonstrated the de-
fined relationship between the tumor and its surround-
ings, such as the normal pituitary gland, cavernous 
sinus, and optic pathway. The pituitary gland enhances 
homogeneously, whereas the microadenoma enhances 
afterwards; therefore, it appears as low signal intensity 
on postcontrast T1weighted image (WI).
Pituitary adenomas are usually soft and easy to ex-
cise by aspiration or curettage. However, fibrous adeno-
mas are more difficult to excise and occur with a certain 
incidence. Predicting fibrous adenomas by MRI is typi-
cally difficult and unreliable. We proposed that brushed 
enhancement was one of the reliable findings for fibrous 
hyperperfusion adenoma. Subsequently, this brushed 
enhancement of fibrous adenomas was identified clearly 
on postcontrast T1WI (Fig. 2). Intratumoral flow void, 
indicating the inferior hypophyseal artery, was demon-
strated clearly on T2WI in some hypervascular cases. In 
our study, intratumoral flow void was depicted clearly 
in nine of 72 cases (12.5%) on T2WI. Recently, we have 
performed arterial spin-labeled perfusion imaging (ASL) 
to measure the blood flow of pituitary macroadenomas 
preoperatively. ASL is an MRI technique for perfusion 
measurement. This technique requires no extrinsic 
tracer, such as gadolinium chelates. Instead, it uses 
electromagnetically labeled arterial blood water as 
an intrinsic tracer. Sakai et al. reported that ASL was 
useful in the preoperative prediction of intra- and post-
operative tumor hemorrhage, consistent with our study 
findings.8
The incidence of hemorrhage within pituitary 
adenoma, so called pituitary apoplexy, ranges between 
1.9% and 26.5%.9–11 Asymptomatic pituitary apoplexy 
is being frequently diagnosed owning to recent advanc-
es in MRI. In our study, in four of 17 cases, hemorrhage 
was detected in pituitary adenomas by susceptibility 
WI, but not by T2WI. We suggest that susceptibility 
WI should be used to provide diagnostic assistance for 
pituitary apoplexy.12
Pituitary adenomas are clinically classified into two 
groups, namely, functioning and non-functioning ad-
enomas. The characteristic MRI findings of functioning 
pituitary adenoma, such as ACTH, GH, and prolactin 
(PRL)-producing adenoma, are reviewed.
Approximately 90% of pituitary adenomas 
causing Cushing’s disease (CD) are microadenomas 
with a diameter of less than 10 mm. As adenomas 
of 5 mm or less are frequent, a large percentage of 
these microadenomas cannot be visualized by high 
resolution MRI.13 Transsphenoidal surgery is the first-
choice treatment for CD. The surgical cure rate for CD 
is approximately 80–90% when a tumor is visible on 
MRI.14 It decreases to 50–70% when the lesion can-
not be localized on MRI.14 Correct localization of the 
tumor on MRI helps in improving the surgical cure rate. 
Although many authors advocate dynamic study as a 
technique to increase sensitivity to microadenomas, 
the spatial resolution of dynamic contrast-enhanced 
MRI is poor. Patronas et al. recommend the addition of 
SPGR sequences characterized by superior soft tissue 
contrast using pituitary-specific technical parameters to 
improve the MRI detection of ACTH-secreting pituitary 
tumors.15 Volume interpolated 3D-spoiled gradient MRI 
sequence, which is similar to SPGR sequence, is better 
for localization of pituitary microadenomas in CD than 
dynamic contrast SE sequence.16 We also propose that 
3D-SPGR sequence is the more suitable sequence for 
detecting the microadenoma using the current state-of-
the-art high-field MRI (Fig. 3).
Fig. 1. Sagittal postcontrast T1-weighted MR images of a 
55-year-old woman with hypothyroidism during thyroxine re-
placement therapy. (a) Before therapy. A pituitary hyperplasia is 
visible as an enhanced lesion. (b) At 5 months. (c) At 18 months. 
The enhanced lesion has decreased considerably.
Fig. 2. Postcontrast T1-weighted MR images of a 61-year-old man 
with a non-functioning fibrous macroadenoma. An arrow indi-
cates brushed enhancement. (a) Coronall view (b) Sagittal view.
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Transsphenoidal surgery is the f irst-choice 
treatment for acromegaly. Unless the patients have 
achieved endocrinological remission after surgery, 
medical and/or radiation therapy should be considered. 
Somatostatin analogues represent the first-choice 
medical treatment for acromegaly. Numerous factors 
are associated with resistance somatostatin analogues, 
including sparsely granulated adenoma subtype. The 
sparsely granulated adenoma is more aggressive tumor. 
Predicting treatment response of somatostatin ana-
logues is necessary, and signal intensity on T2WI may 
improve preoperative classification of GH-producing 
adenomas.17 Characteristic features of GH-producing 
pituitary adenomas have been reported. For example, 
GH-producing adenomas tend to demonstrate infrasel-
lar extension (Fig. 4). Empty sella is also associated in 
some cases. In GH-producing adenomas, T2-weighted 
MRI signal intensity is a marker for granulation pattern. 
Hypointense is almost exclusive for densely granulated 
adenomas.18 Sparsely granulated adenoma has relatively 
hyperintense mass. Using 3T MRI the border of densely 
granulated GH-producing adenomas and tumor contents 
is identified more clearly on T2WI. The pituitary adeno-
ma is depicted clearly as a less enhanced area surround-
ing the normal pituitary gland on postcontrast T1WI 
(Fig. 5). We propose that T2-weighted and postcontrast 
SPGR T1-weighted images are suitable sequences for 
evaluating GH-producing pituitary adenomas at 3T.
Cabergoline has been widely accepted as the pri-
mary treatment for PRL-producing pituitary adenomas, 
because it has higher efficacy in normalizing PRL levels 
and reducing tumor mass.19, 20 Although a high per-
centage rate of tumor shrinkage was reported, tumors 
completely disappeared on MRI in only approximately 
20% of cases.21 During treatment with dopamine ago-
nist, variable MRI characteristics have been observed. 
We reported distinct low signal intensity areas on T2WI 
in early phase of treatment, possibly owning to diffuse 
hemorrhage, which indicated pronounced regressions of 
PRL-producing pituitary adenomas during cabergoline 
treatment (Fig. 6).22
CRANIOPHARYNGIOMA
Craniopharyngiomas are sellar and/or suprasellar 
masses that derive from epithelial remnants of the 
Rathke’s pouch. Although histologically benign, these 
Fig. 3. Coronal T1-weighted MR images of the sellar region of a 
15-year-old man with ACTH-producing pituitary microadenoma. 
(a) 1.5T dynamic (b) 1.5T 3D-grdient echo sequence (c) 3T 
3D-SPGR sequence. The 3D-SPGR 3T MR images are superior 
to the other images for visualization of the microadenoma (arrows).
Fig. 4. Postcontrast T1-weighted MR images of a 64-year-old 
woman with acromegaly. (a) Coronall view (b) Sagittal view. 
This patient was transferred to our hospital for the treatment of 
intracranial hemorrhage owning to hypertension. A diagnosis of 
acromegaly was suspected from the clinical features. However, 
the pituitary adenoma could not be detected. Postcontrast T1WI 
revealed a macroadenoma (*) invading into the sphenoid sinus 
inferiorly during the radiological examination.
Fig. 5. Postcontrast coronal T1-weighted (a), and T2-weighted 
(b) MR images of the sellar region of a 42-year-old man with a 
GH-producing pituitary adenoma (densely granulated type). The 
adenoma is clearly visible as a low signal intense mass (arrows). 
The tumor was excised entirely by the endonasal approach. 
Histopathological diagnosis of a densely granulated somatotroph 
adenoma was established.
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tumors frequently recur after surgery. The two histo-
pathological subtypes, adamantinomatous and squa-
mous papillary craniopharyngioma, differ in genesis 
and age distribution.23 On MRI, these lesions have a 
heterogenous appearance with a solid portion and cystic 
components. The typical appearance of adamantinoma-
tous craniopharyngioma is multilobulated and partially 
solid; however, they are mostly a cystic suprasellar mass 
(Fig. 7). The cysts often contain “machinery oil” fluid. 
Calcified tumors are mostly of the adamantinomatous 
type. Characteristic rim and nodular calcifications are 
best detected on computed tomography. Squamous 
papillary craniopharyngioma is a typically discrete 
encapsulated tumor with a smooth surface that does 
not adhere to the adjacent brain. The cysts contain clear 
fluid. Recent insights into the molecular pathogenesis of 
craniopharyngiomas opened new perspectives on tar-
geted therapy in squamous papillary craniopharyngioma 
harboring BRAF-V600E mutations. Adamantinomatous 
craniopharyngiomas are driven by somatic mutations in 
CTNNB1 (encoding β-catenin).
RATHKE CLEFT CYST
Rathke cleft cysts (RCCs) are benign sellar and/
or suprasellar cysts that arise from the remnants of 
Rathke’s pouch. Signal intensity varies with cyst con-
tents. RCCs of high- and iso signal intensity on T1WI, 
which contain mucous material, may be associated 
with chronic inflammation that can potentially cause 
irreversible endocrine dysfunction.24 However, patients 
with low signal intensity content tend to experience 
visual disturbances.24 Although cyst f luid of RCC 
shows variable intensities on MRI, intracystic waxy 
nodule is hypointense on T2WI (Fig. 8).25 The enhanc-
ing cyst wall may contain the squamous metaplasia. 
Symptomatic RCCs are mostly treated by draining the 
cyst contents with partial removal of the cyst wall. The 
Fig. 6. Coronal T2-weighted MR images of the sellar region of a 37-year-old man with a PRL-producing adenoma during cabergoline 
treatment. This patient was referred to our hospital, complaining of a headache and visual disturbance. Cabergoline treatment was initi-
ated as the serum PRL was over 470 ng/mL. Tumor size has decreased considerably. (a) Before therapy, a macroadenoma is visible as a 
high signal intensity area. (b) At 4 months, a low signal intensity area, possibly owning to diffuse hemorrhage, has developed throughout 
the adenoma. Thereafter, the tumor decreased considerably in size. (c) At 1 year, the formerly low signal intensity region has transformed 
into a high signal intensity area slightly. (d) At 3 years, intracavernous sinus area finally demonstrates high signal intensity.
Fig. 7. Precontrast CT (a) and postcontrast MR images (b, c, d) of 
the sellar region of a 47-year-old woman with craniopharyngioma. 
Chunky and irregular calcification (arrow) of the suprasellar mass 
is more clearly visible on CT rather than MRI. MR images depicts 
the solid and cystic mass clearly.
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reported recurrence rates have ranged between 10% 
and 42%, a relatively high percentage. The presence of 
squamous metaplasia in the cyst wall was associated 
with the recurrence after surgery.26, 27 Spontaneous 
regression of RCC may not be rare after presenting with 
severe headache.28
XANTHOGRANULOMA OF THE SELLAR REGION
Paulus et al. suggest that xanthogranuloma of the sellar 
region is clinically and pathologically different from 
the classical adamantinomatous craniopharyngioma.29 
In 2000, the World Health Organization accepted 
xanthogranuloma of the sellar region as a distinct entity. 
These lesions consist largely of cholesterol clefts, mac-
rophages, and chronic inflammatory infiltrates without 
epithelium. Typical radiological findings have not been 
reported yet. These lesions show variable signal inten-
sity on T2WI in our experience. Most are high signal 
intensities on T1WI. Hemosiderin rims are found in 
some cases (Fig. 9).
Cystic lesions of the sellar and/or parasellar areas 
are difficult to differentiate on clinical, imaging, or 
even a histopathological basis. Several varieties of 
“transitional” or “crossover” cystic epithelial lesions 
have been reported in the literature.30 One of them is 
RCC with squamous metaplasia. The higher recurrence 
rates observed in these cases support the idea that 
they likely show more aggressive behavior. Ciliated 
craniopharyngioma is also considered to represent a 
transitional stage between RCC and squamous papillary 
craniopharyngioma.30
NEUROHYPOPHYSEAL GERMINOMA
Germ cell tumors are divided into two groups, namely 
germinoma and nongerminomatous germ cell tumors. 
Germ cell tumors tend to occur at the midline, such as 
the neurohypophysis, around the third ventricle, and 
pineal region.31 Synchronous intracranial germ cell 
tumor in the pineal and neurohypophyseal region is rare 
(Fig. 10). Infundibular thickening and absence of the 
posterior pituitary high signal intensity spot on T1WI 
are common imaging features of neurohypophyseal 
germinoma. Recently, Morana et al. reported that 
all nongerminomatous germ cell tumors showed 
susceptibility WI or T2WI hypointensity, whereas all 
but one pure germinoma were isointense or hyperin-
tense among midline germ cell tumor.32 Subsequently, 
Fig. 8. Precontrast T1-weighted (a, c), T2-weighted (b), and post-
contrast T1-weighted images (d) of the sellar region of a 36-year-
old woman with a Rathke cleft cyst. Mural waxy nodule is clearly 
visible as a low signal intense mass (arrow). The cyst is situated 
between anterior (*) and posterior pituitary gland.
Fig. 9. Coronal precontrast T1-weighted (a), postcontrast T1 
weighted (b), and T2-weighted (c) MR images of a 60-year-old 
man with a xanthogranuloma of the sellar region. Thin enhanced 
lesion is formed by a thin rim of compressed pituitary gland and 
stalk (arrow). Cyst contents show variable signal intensity on 
T2WI. Hemosiderin rim are detected.
Fig. 10. Postcontrast T1-weighted MR images of a 42-year-
old man with a germ cell tumor. (a) Coronall view. A swollen 
pituitary stalk is visible as an enhanced lesion. (b) Sagittal view. 
A pineal lesion (arrow) is also present.
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they recommend the T2*-based MRI in differentiating 
pure germinomas from nongerminomatous germ cell 
tumors.
LYMPHOCYTIC HYPOPHYSITIS
Primary hypophysitis is classified by histologic appear-
ance as lymphocytic, granulomatous, xanthomatous, 
immunoglobulin G4 plasmacytic,33 and mixed form. 
Lymphocytic hypophysitis is an inflammatory disorder 
of the pituitary gland, which occurs in the adenohy-
pophysis and/or infundibulo-neurohypophysis.34, 35 
Lymphocytic hypophysitis is often misdiagnosed 
because its clinical and radiological features mimic 
tumors in the sellar region. When the inflammatory 
process is limited to the infundibulo-neurohypophysis, 
infundibular thickening and absence of the posterior 
pituitary high signal intensity spot are common on 
T1WI (Fig. 11). Differentiation from other stalk lesions, 
such as germinoma and Langerhans cell histiocytosis, 
may be difficult. Dark-signal intensity areas on T2WI 
around the pituitary gland and in the cavernous sinus, 
namely the parasellar T2 dark sign was reported as a 
characteristic feature useful for distinguishing pituitary 
adenoma from this disease in patients with lymphocytic 
hypophysitis.36
CONCLUSION
Our clinical experience with 3T MR images was reported 
with emphasis on hypothalamic and pituitary tumors. 
Because of the high signal-to-noise ratio, 3T MRI was 
superior to 1.5T MRI in visualization of tumors, as well 
as the surroundings. Especially, T2WI and postcontrast 
SPGR T1WI provide high anatomical and contrast 
resolution. These images demonstrate the defined rela-
tionship between the tumor and its surroundings, such 
as the normal pituitary gland, the cavernous sinus, and 
the optic pathway.
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